Benzinga | Aug 17, 2021 04:15PM EDT

GlaxoSmithKline Reports Received FDA Accelerated Approval For Jemperli For Adult Patients With Mismatch Repair-Deficient Recurrent, Advanced Solid Tumors

-Reuters